NCT01555398

Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule

Open-label, Randomized Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Fenofibric Acid for HIP0901 Capsule in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the effect of food on the pharmacokinetic characteristics of fenofibric acid for HIP0901 capsule.

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	HIP0901 capsule (Fenofibric acid) Fasting conditions/ Fed conditions	The study drug(HIP0901 capsule(Fenofibric acid, 135mg)) will be administrated under fed or fasting conditions

Timeline

• Start date: 2012-02-01
• Primary completion: 2012-03-01
• Completion: 2012-05-01
• First posted: 2012-03-15
• Last updated: 2013-04-08

Locations

1 site across 1 country: South Korea